Helix BioMedix Inc. (OTCMKTS:HXBM – Get Free Report) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 87 shares, a decrease of 57.4% from the August 31st total of 204 shares. Based on an average trading volume of 901 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.
Helix BioMedix Stock Performance
Shares of OTCMKTS HXBM traded down $0.60 during mid-day trading on Monday, reaching $4.40. The company had a trading volume of 100 shares, compared to its average volume of 436. The company has a 50-day moving average price of $3.10 and a two-hundred day moving average price of $2.05. Helix BioMedix has a 1-year low of $1.00 and a 1-year high of $6.50.
About Helix BioMedix
Helix BioMedix, Inc is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides for personal-care, cosmetic and related life-science applications. Its work centers on peptides designed to support skin health and appearance, including products used in anti-aging, skin-repair and antimicrobial formulations.
The company develops proprietary peptide ingredients and licenses or supplies them to manufacturers and formulators for use in skincare and other topical products.
Featured Stories
- Five stocks we like better than Helix BioMedix
- 3 Dividend Stocks Investors May Be Missing in 2026
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
- 3 Stocks Under the Microscope After Large Insider Sales
Receive News & Ratings for Helix BioMedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioMedix and related companies with MarketBeat.com's FREE daily email newsletter.
